IRCT20101107005123N3尚未招募3 期
Evaluation of the effect of silymarin in patients with inflammatory bowel disease
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 5 years 至 18 years（—）
- 性别
- All
入选标准
- •Inflammatory bowel disease
排除标准
- •The patient's unwillingness to visit the gastroenterology clinic regularly for regular examinations and check-ups
- •Presence of any other comorbidities
研究者
相似试验
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60
已完成
3 期
The effect of silymarin on methadone poisoningIRCT20210216050377N1Shahre-kord University of Medical Sciences64
招募中
3 期
Evaluating the effect of silymarin oral form on the control of liver toxicity caused by adriamycin and cyclophosphamide drugs in patients with non metastatic breast cancerIRCT2017091136125N1Vice chancellor for research, Mashhad University of Medical Sciences40
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140
已完成
2 期
To evaluate the effectiveness of Silymarin (Livergol) on IL-6 levels and size of endometrioma lesionsIRCT20150905023897N5Vice chancellor for research Tarbiat Modares University60